Danaher用$180/share 买下Masimo $180/share 在9.9B的交易中,2026年底结束。 Danaher to buy Masimo for $180/share in $9.9B deal, closing late 2026.

Danaher同意在99亿美元的全部现金交易中收购Masimo, 每股支付180美元, 比Masimo之前的结账价高出38.3%。 Danaher has agreed to acquire Masimo in a $9.9 billion all-cash deal, paying $180 per share, a 38.3% premium over Masimo’s prior closing price. 这次采购预期于2026年底结束,目的是加强Danaher对Mamimo的非侵入性监测技术(包括脉冲血氧计)的诊断组合。 The acquisition, expected to close in late 2026, aims to strengthen Danaher’s diagnostics portfolio with Masimo’s non-invasive monitoring technologies, including pulse oximeters. Masimo面临与苹果的专利争议,最近退出消费音频市场,市场上限约为70亿美元。 Masimo, facing ongoing patent disputes with Apple and recently exiting the consumer audio market, has a market cap of about $7 billion. 这笔交易预计将提高Danaher的收入, 使其收入多样化, The deal is projected to boost Danaher’s earnings and diversify its revenue amid challenges in healthcare funding, regulation, and pricing.